Clinical Trial Update: Clinical Study Of Schizophrenia in Both Men and Women [Phase 3]

View source ↗

Summary

A Phase 3 clinical study evaluating a schizophrenia treatment sponsored by GlaxoSmithKline has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED